These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32894560)

  • 1. Microencapsulated islet allografts in diabetic NOD mice and nonhuman primates.
    Safley SA; Kenyon NS; Berman DM; Barber GF; Cui H; Duncanson S; De Toni T; Willman M; De Vos P; Tomei AA; Sambanis A; Kenyon NM; Ricordi C; Weber CJ
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8551-8565. PubMed ID: 32894560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin-diabetic non-human primates.
    Safley SA; Kenyon NS; Berman DM; Barber GF; Willman M; Duncanson S; Iwakoshi N; Holdcraft R; Gazda L; Thompson P; Badell IR; Sambanis A; Ricordi C; Weber CJ
    Xenotransplantation; 2018 Nov; 25(6):e12450. PubMed ID: 30117193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencapsulated adult porcine islets.
    Cui H; Tucker-Burden C; Cauffiel SM; Barry AK; Iwakoshi NN; Weber CJ; Safley SA
    Transplantation; 2009 Jul; 88(2):160-9. PubMed ID: 19623010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple clinically relevant immunotherapies prolong the function of microencapsulated porcine islet xenografts in diabetic NOD mice without the use of anti-CD154 mAb.
    Safley SA; Barber GF; Holdcraft RW; Gazda LS; Duncanson S; Poznansky MC; Sambanis A; Weber CJ
    Xenotransplantation; 2020 Jul; 27(4):e12577. PubMed ID: 31903659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of microencapsulated islets at 400 days posttransplantation in the omental pouch of NOD mice.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanga M; Ko S; Nagao M; Harb G; Nakajima Y
    Cell Transplant; 2006; 15(4):359-65. PubMed ID: 16898230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-transplantation of islets with mesenchymal stem cells in microcapsules demonstrates graft outcome can be improved in an isolated-graft model of islet transplantation in mice.
    Kerby A; Jones ES; Jones PM; King AJ
    Cytotherapy; 2013 Feb; 15(2):192-200. PubMed ID: 23321331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged glucose normalization of streptozotocin-induced diabetic mice by transplantation of rat islets coencapsulated with crosslinked hemoglobin.
    Chae SY; Kim YY; Kim SW; Bae YH
    Transplantation; 2004 Aug; 78(3):392-7. PubMed ID: 15316367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevascularized Retrievable Hybrid Implant to Enhance Function of Subcutaneous Encapsulated Islets.
    Mridha AR; Dargaville TR; Dalton PD; Carroll L; Morris MB; Vaithilingam V; Tuch BE
    Tissue Eng Part A; 2022 Mar; 28(5-6):212-224. PubMed ID: 33081600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
    Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
    Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of laminin-biodritin microcapsules for type 1 diabetes mellitus.
    Campanha-Rodrigues AL; Grazioli G; Oliveira TC; Campos-Lisbôa AC; Mares-Guia TR; Sogayar MC
    Cell Transplant; 2015; 24(2):247-61. PubMed ID: 24256689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term function and immune-protection of microencapsulated adult porcine islets with alginate incorporating CXCL12 in healthy and diabetic non-human primates without systemic immune suppression: A pilot study.
    Sremac M; Luo H; Deng H; Parr MFE; Hutcheson J; Verde PS; Alagpulinsa DA; Kitzmann JM; Papas KK; Brauns T; Markmann JF; Lei J; Poznansky MC
    Xenotransplantation; 2023; 30(6):e12826. PubMed ID: 37712342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod mice.
    Weber CJ; Zabinski S; Koschitzky T; Wicker L; Rajotte R; D'Agati V; Peterson L; Norton J; Reemtsma K
    Transplantation; 1990 Feb; 49(2):396-404. PubMed ID: 1968298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated functional maturation of isolated neonatal porcine cell clusters: in vitro and in vivo results in NOD mice.
    Luca G; Nastruzzi C; Calvitti M; Becchetti E; Baroni T; Neri LM; Capitani S; Basta G; Brunetti P; Calafiore R
    Cell Transplant; 2005; 14(5):249-61. PubMed ID: 16052907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets.
    Tatarkiewicz K; Garcia M; Omer A; Van Schilfgaarde R; Weir GC; De Vos P
    Diabetologia; 2001 May; 44(5):646-53. PubMed ID: 11380084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets.
    King A; Lau J; Nordin A; Sandler S; Andersson A
    Diabetes Technol Ther; 2003; 5(4):653-63. PubMed ID: 14511420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 4: Pre-clinical efficacy and complication data required to justify a clinical trial.
    Cooper DK; Casu A
    Xenotransplantation; 2009; 16(4):229-38. PubMed ID: 19799763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and transplantation of agarose microencapsulated canine islets of Langerhans.
    Tashiro H; Iwata H; Warnock GL; Takagi T; Machida H; Ikada Y; Tsuji T
    Ann Transplant; 1997; 2(3):33-9. PubMed ID: 9869862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
    Solomon M; Flodström-Tullberg M; Sarvetnick N
    Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.